-
1
-
-
0036316256
-
Hospitalizations for cytomegalovirus disease after renal transplantation in the United States
-
Abbott K.C., Hypolite I.O., Viola R., et al. Hospitalizations for cytomegalovirus disease after renal transplantation in the United States. Ann Epidemiol 12 (2002) 402
-
(2002)
Ann Epidemiol
, vol.12
, pp. 402
-
-
Abbott, K.C.1
Hypolite, I.O.2
Viola, R.3
-
2
-
-
0036756210
-
Side effects of mycophenolate mofetil versus azathioprine in iranian renal transplant recipients (single-center experience)
-
Hakemi M., Shahebrahimi K., Ganji M.R., et al. Side effects of mycophenolate mofetil versus azathioprine in iranian renal transplant recipients (single-center experience). Transplant Proc 34 (2002) 2091
-
(2002)
Transplant Proc
, vol.34
, pp. 2091
-
-
Hakemi, M.1
Shahebrahimi, K.2
Ganji, M.R.3
-
3
-
-
27644540081
-
The impact of mycophenolate mofetil on long-term outcomes in kidney transplantation
-
Srinivas T.R., Kaplan B., Schold J.D., et al. The impact of mycophenolate mofetil on long-term outcomes in kidney transplantation. Transplantation 80 2 suppl (2005) S211
-
(2005)
Transplantation
, vol.80
, Issue.2 SUPPL
-
-
Srinivas, T.R.1
Kaplan, B.2
Schold, J.D.3
-
4
-
-
21844440799
-
Comparison of long-term actual renal allograft survival in mycophenolate mofetil and azathioprine-based triple drug immunosuppression protocols
-
Attallah N., Goggins M., Nori U., et al. Comparison of long-term actual renal allograft survival in mycophenolate mofetil and azathioprine-based triple drug immunosuppression protocols. Transplant Proc 37 (2005) 2060
-
(2005)
Transplant Proc
, vol.37
, pp. 2060
-
-
Attallah, N.1
Goggins, M.2
Nori, U.3
-
5
-
-
19044379570
-
Effect of new immunosuppressive regimens on cost of renal transplant maintenance immunosuppression
-
Gentil M.A., Gonzalez-Roncero F., Cantarell C., et al. Effect of new immunosuppressive regimens on cost of renal transplant maintenance immunosuppression. Transplant Proc 37 (2005) 1441
-
(2005)
Transplant Proc
, vol.37
, pp. 1441
-
-
Gentil, M.A.1
Gonzalez-Roncero, F.2
Cantarell, C.3
-
6
-
-
0032963401
-
Ten-year cost effectiveness of alternative immunosuppression regimens in cadaveric renal transplantation
-
Schnitzler M.A., Woodward R.S., Lowell J.A., et al. Ten-year cost effectiveness of alternative immunosuppression regimens in cadaveric renal transplantation. Transplant Proc 31 3B suppl (1999) 19S
-
(1999)
Transplant Proc
, vol.31
, Issue.3 B SUPPL
-
-
Schnitzler, M.A.1
Woodward, R.S.2
Lowell, J.A.3
-
7
-
-
34248563485
-
-
6-7: Tue, Oct 31, Available at: http://www.iran-daily.com/1385/2695/html/focus.html
-
Dispute Over Inflation Rate. Iran Daily (2006). http://www.iran-daily.com/1385/2695/html/focus.html 6-7: Tue, Oct 31, Available at: http://www.iran-daily.com/1385/2695/html/focus.html
-
(2006)
Dispute Over Inflation Rate. Iran Daily
-
-
-
8
-
-
34248565048
-
-
Roshandel D, Rezailashkajani M, Shafaee S, et al: A cost analysis of functional bowel disorders in Iran. Int J Colorectal Dis (in press)
-
-
-
-
9
-
-
0032946534
-
Reduced kidney transplant rejection rate and pharmacoeconomic advantage of mycophenolate mofetil
-
Wuthrich R.P., Weinreich T., Ambuhl P.M., et al. Reduced kidney transplant rejection rate and pharmacoeconomic advantage of mycophenolate mofetil. Nephrol Dial Transplant 14 (1999) 394
-
(1999)
Nephrol Dial Transplant
, vol.14
, pp. 394
-
-
Wuthrich, R.P.1
Weinreich, T.2
Ambuhl, P.M.3
-
10
-
-
0031831893
-
Conversion to mycophenolate mofetil for chronic progressive deterioration of renal allograft function: first clinical experiences in 44 patients
-
Fritsche L., Sperschneider H., Budde K., et al. Conversion to mycophenolate mofetil for chronic progressive deterioration of renal allograft function: first clinical experiences in 44 patients. Transplant Proc 30 (1998) 1190
-
(1998)
Transplant Proc
, vol.30
, pp. 1190
-
-
Fritsche, L.1
Sperschneider, H.2
Budde, K.3
-
11
-
-
0034082485
-
The use of mycophenolate mofetil in transplant recipients
-
Mele T.S., and Halloran P.F. The use of mycophenolate mofetil in transplant recipients. Immunopharmacology 47 (2000) 215
-
(2000)
Immunopharmacology
, vol.47
, pp. 215
-
-
Mele, T.S.1
Halloran, P.F.2
-
12
-
-
85047233807
-
Clinical and cost-effectiveness of newer immunosuppressive regimens in renal transplantation: a systematic review and modelling study
-
Woodroffe R., Yao G.L., Meads C., et al. Clinical and cost-effectiveness of newer immunosuppressive regimens in renal transplantation: a systematic review and modelling study. Health Technol Assess 9 (2005) 1
-
(2005)
Health Technol Assess
, vol.9
, pp. 1
-
-
Woodroffe, R.1
Yao, G.L.2
Meads, C.3
-
13
-
-
0036216535
-
Infections in renal transplant recipients receiving mycophenolate versus azathioprine-based immunosuppression
-
Bernabeu-Wittel M., Naranjo M., Cisneros J.M., et al. Infections in renal transplant recipients receiving mycophenolate versus azathioprine-based immunosuppression. Eur J Clin Microbiol Infect Dis 21 (2002) 173
-
(2002)
Eur J Clin Microbiol Infect Dis
, vol.21
, pp. 173
-
-
Bernabeu-Wittel, M.1
Naranjo, M.2
Cisneros, J.M.3
-
14
-
-
0038346035
-
Mycophenolate mofetil is associated with less death with function than azathioprine in cadaveric renal transplantation
-
Schnitzler M.A., Craig K.E., Hardinger K.E., et al. Mycophenolate mofetil is associated with less death with function than azathioprine in cadaveric renal transplantation. Nephrol Dial Transplant 18 (2003) 1197
-
(2003)
Nephrol Dial Transplant
, vol.18
, pp. 1197
-
-
Schnitzler, M.A.1
Craig, K.E.2
Hardinger, K.E.3
-
15
-
-
15844401967
-
Mycophenolate mofetil vs. azathioprine is associated with decreased acute rejection, late acute rejection, and risk for cardiovascular death in renal transplant recipients with pre-transplant diabetes
-
David K.M., Morris J.A., Steffen B.J., et al. Mycophenolate mofetil vs. azathioprine is associated with decreased acute rejection, late acute rejection, and risk for cardiovascular death in renal transplant recipients with pre-transplant diabetes. Clin Transplant 19 (2005) 279
-
(2005)
Clin Transplant
, vol.19
, pp. 279
-
-
David, K.M.1
Morris, J.A.2
Steffen, B.J.3
-
16
-
-
33745261588
-
Mycophenolate mofetil reduces intimal thickness by intravascular ultrasound after heart transplant: reanalysis of the multicenter trial
-
Kobashigawa J.A., Tobis J.M., Mentzer R.M., et al. Mycophenolate mofetil reduces intimal thickness by intravascular ultrasound after heart transplant: reanalysis of the multicenter trial. Am J Transplant 6 5 Pt 1 (2006) 993
-
(2006)
Am J Transplant
, vol.6
, Issue.5 PART 1
, pp. 993
-
-
Kobashigawa, J.A.1
Tobis, J.M.2
Mentzer, R.M.3
-
17
-
-
0036755866
-
Effect of mycophenolate mofetil on the prevention of acute renal allograft rejection
-
Miladipour A.H., Ghods A.J., and Nejadgashti H. Effect of mycophenolate mofetil on the prevention of acute renal allograft rejection. Transplant Proc 34 (2002) 2089
-
(2002)
Transplant Proc
, vol.34
, pp. 2089
-
-
Miladipour, A.H.1
Ghods, A.J.2
Nejadgashti, H.3
-
18
-
-
0029006409
-
Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection
-
European Mycophenolate Mofetil Cooperative Study Group
-
European Mycophenolate Mofetil Cooperative Study Group. Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection. Lancet 345 (1995) 1321
-
(1995)
Lancet
, vol.345
, pp. 1321
-
-
-
19
-
-
0006986048
-
A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric kidney transplantation
-
The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group
-
The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric kidney transplantation. Transplantation 61 (1996) 1029
-
(1996)
Transplantation
, vol.61
, pp. 1029
-
-
-
20
-
-
0031002738
-
Mycophenolate mofetil for the prevention of acute rejection of primary cadaveric kidney transplants: status of the MYC 1866 study at 1 year
-
The U.S. Mycophenolate Mofetil Study Group
-
The U.S. Mycophenolate Mofetil Study Group. Mycophenolate mofetil for the prevention of acute rejection of primary cadaveric kidney transplants: status of the MYC 1866 study at 1 year. Transplant Proc 29 (1997) 348
-
(1997)
Transplant Proc
, vol.29
, pp. 348
-
-
-
21
-
-
14944366253
-
Infectious complications in using mofetil micofenolate in patients with renal allotransplant
-
Prokopenko E.I., Shcherbakova E.O., Vatazin A.V., et al. Infectious complications in using mofetil micofenolate in patients with renal allotransplant. Ter Arkh 77 (2005) 67
-
(2005)
Ter Arkh
, vol.77
, pp. 67
-
-
Prokopenko, E.I.1
Shcherbakova, E.O.2
Vatazin, A.V.3
-
22
-
-
0034093791
-
The influence of mycophenolate mofetil on the incidence and severity of primary cytomegalovirus infections and disease after renal transplantation
-
Ter Meulen C.G., Wetzels J.F.M., and Hilbrands L.B. The influence of mycophenolate mofetil on the incidence and severity of primary cytomegalovirus infections and disease after renal transplantation. Nephrol Dial Transplant 15 (2000) 711
-
(2000)
Nephrol Dial Transplant
, vol.15
, pp. 711
-
-
Ter Meulen, C.G.1
Wetzels, J.F.M.2
Hilbrands, L.B.3
-
23
-
-
0031663952
-
Is cytomegalovirus infection related to mycophenolate mofetil after kidney transplantation?. A case-control study
-
Sarmiento J.M., Munn S.R., Paya C.V., et al. Is cytomegalovirus infection related to mycophenolate mofetil after kidney transplantation?. A case-control study. Clin Transplant 12 (1998) 371
-
(1998)
Clin Transplant
, vol.12
, pp. 371
-
-
Sarmiento, J.M.1
Munn, S.R.2
Paya, C.V.3
-
24
-
-
0034911679
-
Mycophenolate mofetil does not modify the incidence of cytomegalovirus (CMV) disease after kidney transplantation but prevents CMV-induced chronic graft dysfunction
-
Giral M., Nguyen J.M., Daguin P., et al. Mycophenolate mofetil does not modify the incidence of cytomegalovirus (CMV) disease after kidney transplantation but prevents CMV-induced chronic graft dysfunction. J Am Soc Nephrol 12 (2001) 1758
-
(2001)
J Am Soc Nephrol
, vol.12
, pp. 1758
-
-
Giral, M.1
Nguyen, J.M.2
Daguin, P.3
-
25
-
-
0034026538
-
Mycophenolate mofetil increases cytomegalovirus invasive organ disease in renal transplant patients
-
Sarmiento J.M., Dockrell D.H., Schwab T.R., et al. Mycophenolate mofetil increases cytomegalovirus invasive organ disease in renal transplant patients. Clin Transplant 14 (2000) 136
-
(2000)
Clin Transplant
, vol.14
, pp. 136
-
-
Sarmiento, J.M.1
Dockrell, D.H.2
Schwab, T.R.3
-
26
-
-
0036224139
-
Mycophenolate mofetil immunosuppressive therapies increase the incidence of cytomegalovirus infection in renal transplantation
-
Munoz M.A., Andres A., Gallego R., et al. Mycophenolate mofetil immunosuppressive therapies increase the incidence of cytomegalovirus infection in renal transplantation. Transplant Proc 34 (2002) 97
-
(2002)
Transplant Proc
, vol.34
, pp. 97
-
-
Munoz, M.A.1
Andres, A.2
Gallego, R.3
|